In this review, we summarize our current understanding of the pathogenetic involvement of OT in atherosclerosis, the cellular/molecular mechanisms underlying OT suppression of atherosclerosis development and current challenges in clinical trials of OT. This evidence concerns the gene OXT and atherosclerosis.